Delivery Order SPE2DR25D2014-SPE2DR26FZ89G
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $8,094.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $3,036.82. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is set for ultimate completion by November 6, 2025, and will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Concerta ER 36 mg tablets (100-count bottles) valued at $6,791.05 with a firm fixed price arrangement. This non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Concerta ER Tabs 36mg pharmaceutical products. This firm fixed-price delivery order, valued at $20,665.92, is scheduled for completion by October 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation, reflecting...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Concerta ER 36 mg tablets (100-count packaging) valued at $2,786.94. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $10,909.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100-count units) valued at $10,096.03 on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,836.73 and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $45,795.06. This is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ89GDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $7,023.99. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its role as a critical vendor for the Defense Health Agency and other government healthcare systems, delivering medications across multiple therapeutic domains including neurological, pain management, and specialty pharmaceuticals to support military personnel and veteran care requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/4/25 |